Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshitaka Sekido

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Carcinogenesis|May 17, 2013
Molecular pathogenesis of malignant mesotheliomaYoshitaka Sekido
Cancers|March 23, 2018
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant MesotheliomaYoshitaka Sekido
Cancer Science|October 2, 2009
Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cellsYoshitaka Sekido
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2002
[Tumor markers for lung neoplasm]Yoshitaka Sekido
Pathology International|May 28, 2011
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulationYoshitaka Sekido
Environmental Health and Preventive Medicine|July 2, 2009
Molecular biology of malignant mesotheliomaYoshitaka Sekido
Frontiers in Toxicology|May 14, 2023
NF2 alteration in mesotheliomaYoshitaka Sekido, Tatsuhiro Sato
International Journal of Molecular Sciences|March 29, 2018
NF2/Merlin Inactivation and Potential Therapeutic Targets in MesotheliomaTatsuhiro Sato, Yoshitaka Sekido
Cell Reports|March 22, 2016
Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo IndependentHiroki Hikasa, Yoshitaka Sekido, Akira Suzuki
Annual Review of Medicine|December 10, 2002
Molecular genetics of lung cancerYoshitaka Sekido, Kwun M Fong, John D Minna
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Carcinogenesis|May 17, 2013
Molecular pathogenesis of malignant mesotheliomaYoshitaka Sekido
Cancers|March 23, 2018
Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant MesotheliomaYoshitaka Sekido
Cancer Science|October 2, 2009
Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cellsYoshitaka Sekido
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2002
[Tumor markers for lung neoplasm]Yoshitaka Sekido
Pathology International|May 28, 2011
Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulationYoshitaka Sekido
Environmental Health and Preventive Medicine|July 2, 2009
Molecular biology of malignant mesotheliomaYoshitaka Sekido
Frontiers in Toxicology|May 14, 2023
NF2 alteration in mesotheliomaYoshitaka Sekido, Tatsuhiro Sato
International Journal of Molecular Sciences|March 29, 2018
NF2/Merlin Inactivation and Potential Therapeutic Targets in MesotheliomaTatsuhiro Sato, Yoshitaka Sekido
Cell Reports|March 22, 2016
Merlin/NF2-Lin28B-let-7 Is a Tumor-Suppressive Pathway that Is Cell-Density Dependent and Hippo IndependentHiroki Hikasa, Yoshitaka Sekido, Akira Suzuki
Annual Review of Medicine|December 10, 2002
Molecular genetics of lung cancerYoshitaka Sekido, Kwun M Fong, John D Minna
Pageof 15